Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States.

ABSTRACT: INTRODUCTION:The prevalence of endometriosis and the need for treatment in the USA has led to the need to explore the contemporary cost burden associated with the disease. This retrospective cohort study compared direct and indirect healthcare costs in patients with endometriosis to a control group without endometriosis. METHODS:Women aged 18-49 years with endometriosis (date of initial diagnosis = index date) were identified in the Truven Health MarketScan® Commercial database between 2010 and 2014 and female control patients without endometriosis were matched by age and index year. The following outcomes were compared: healthcare resource utilization (HRU) during the 12-month pre- and post-index periods (including inpatient admissions, pharmacy claims, emergency room visits, physician of

SUBMITTER: Soliman AM 

PROVIDER: S-EPMC5859693 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature